Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $10.36 billion. The enterprise value is $9.16 billion.
| Market Cap | 10.36B |
| Enterprise Value | 9.16B |
Important Dates
The last earnings date was Monday, July 28, 2025, after market close.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 269.20 million shares outstanding. The number of shares has decreased by -6.02% in one year.
| Current Share Class | 269.20M |
| Shares Outstanding | 269.20M |
| Shares Change (YoY) | -6.02% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 2.49% |
| Owned by Institutions (%) | 81.26% |
| Float | 228.77M |
Valuation Ratios
The trailing PE ratio is 18.54 and the forward PE ratio is 14.75. Exelixis's PEG ratio is 0.66.
| PE Ratio | 18.54 |
| Forward PE | 14.75 |
| PS Ratio | 4.84 |
| Forward PS | 4.30 |
| PB Ratio | 5.11 |
| P/TBV Ratio | 5.26 |
| P/FCF Ratio | 13.74 |
| P/OCF Ratio | 13.42 |
| PEG Ratio | 0.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.72, with an EV/FCF ratio of 12.14.
| EV / Earnings | 15.20 |
| EV / Sales | 4.11 |
| EV / EBITDA | 11.72 |
| EV / EBIT | 12.18 |
| EV / FCF | 12.14 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.51 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.24 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.00% and return on invested capital (ROIC) is 20.74%.
| Return on Equity (ROE) | 29.00% |
| Return on Assets (ROA) | 17.24% |
| Return on Invested Capital (ROIC) | 20.74% |
| Return on Capital Employed (ROCE) | 32.10% |
| Revenue Per Employee | $1.94M |
| Profits Per Employee | $525,107 |
| Employee Count | 1,147 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.44 |
Taxes
In the past 12 months, Exelixis has paid $173.34 million in taxes.
| Income Tax | 173.34M |
| Effective Tax Rate | 22.35% |
Stock Price Statistics
The stock price has increased by +42.93% in the last 52 weeks. The beta is 0.29, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +42.93% |
| 50-Day Moving Average | 42.10 |
| 200-Day Moving Average | 37.63 |
| Relative Strength Index (RSI) | 41.83 |
| Average Volume (20 Days) | 3,941,414 |
Short Selling Information
The latest short interest is 17.37 million, so 6.45% of the outstanding shares have been sold short.
| Short Interest | 17.37M |
| Short Previous Month | 18.27M |
| Short % of Shares Out | 6.45% |
| Short % of Float | 7.59% |
| Short Ratio (days to cover) | 4.76 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.23 billion and earned $602.30 million in profits. Earnings per share was $2.08.
| Revenue | 2.23B |
| Gross Profit | 2.15B |
| Operating Income | 751.74M |
| Pretax Income | 450.97M |
| Net Income | 602.30M |
| EBITDA | 781.52M |
| EBIT | 751.74M |
| Earnings Per Share (EPS) | $2.08 |
Balance Sheet
The company has $791.10 million in cash and $179.84 million in debt, giving a net cash position of $1.21 billion or $4.48 per share.
| Cash & Cash Equivalents | 791.10M |
| Total Debt | 179.84M |
| Net Cash | 1.21B |
| Net Cash Per Share | $4.48 |
| Equity (Book Value) | 2.03B |
| Book Value Per Share | 7.53 |
| Working Capital | 844.65M |
Cash Flow
In the last 12 months, operating cash flow was $772.03 million and capital expenditures -$17.96 million, giving a free cash flow of $754.07 million.
| Operating Cash Flow | 772.03M |
| Capital Expenditures | -17.96M |
| Free Cash Flow | 754.07M |
| FCF Per Share | $2.80 |
Margins
Gross margin is 96.59%, with operating and profit margins of 33.71% and 27.01%.
| Gross Margin | 96.59% |
| Operating Margin | 33.71% |
| Pretax Margin | 34.78% |
| Profit Margin | 27.01% |
| EBITDA Margin | 35.05% |
| EBIT Margin | 33.71% |
| FCF Margin | 33.81% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.02% |
| Shareholder Yield | 6.02% |
| Earnings Yield | 5.81% |
| FCF Yield | 7.28% |
Analyst Forecast
The average price target for Exelixis is $43.65, which is 13.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $43.65 |
| Price Target Difference | 13.41% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 11.59% |
| EPS Growth Forecast (5Y) | 27.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 10.72 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.72 |
| Piotroski F-Score | 6 |